(3R,4R)-A2-32-01

CAS No. 1359752-95-6

(3R,4R)-A2-32-01( —— )

Catalog No. M32751 CAS No. 1359752-95-6

(3R,4R)-A2-32-01 is the (R,R)-enantiomer of A2-32-01 and has potential antibacterial activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 225 Get Quote
5MG 424 Get Quote
25MG 1316 Get Quote
50MG 1711 Get Quote
100MG 2250 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (3R,4R)-A2-32-01
  • Note
    Research use only, not for human use.
  • Brief Description
    (3R,4R)-A2-32-01 is the (R,R)-enantiomer of A2-32-01 and has potential antibacterial activity.
  • Description
    (3R,4R)-A2-32-01 (compound 24(R,R)), the (R,R)-enantiomer of A2-32-01, is a Staphylococcus aureus caseinolytic protease (SaClpP) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1359752-95-6
  • Formula Weight
    301.42
  • Molecular Formula
    C19H27NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 200 mg/mL (663.53 mM; Ultrasonic )
  • SMILES
    C(CCCCCCC=C)[C@@H]1[C@@H](CCC=2C=CC=NC2)OC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Malte Gersch, et al. The mechanism of caseinolytic protease (ClpP) inhibition. Angew Chem Int Ed Engl. 2013 Mar 4;52(10):3009-14.?
molnova catalog
related products
  • Tribuloside

    A new cinnamolyglycoflavonoid 3-cinnamoyltribuloside, its precursor tribuloside and two known flavonoid glycosides afzelin and astilbin were isolated from Heritiera littoralis Dryand (Sterculiaceae) ethanolic leaf extract.

  • Cefprozil hydrate

    Cefprozil hydrate (Cefzil) is a second-generation cephalosporin type antibiotic.

  • PAβN dihydrochloride

    PAβN dihydrochloride is an inhibitor of efflux pump. PAβN reduces the MICs in nine ciprofloxacin-resistant isolates, and in four of these, PAβN increases the susceptibility by twofold.?